Shandong Xinhua Pharmaceutical Company Limited announced earnings results for the half year ended June 30, 2019. For the half year, the company announced total revenue was CNY 3,099.899 million compared to CNY 2,687.680 million a year ago. Operating income was CNY 199.455 million compared to CNY 166.133 million a year ago. Net income was CNY 147.474 million compared to CNY 123.363 million a year ago. Basic earnings per share was CNY 0.24 compared to CNY 0.2 a year ago.